Cargando…
Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells
Increased membrane type-1 matrix metalloproteinase (MT1-MMP) expression in osteosarcoma is predictive of poor prognosis and directs bone metastasis in prostate carcinoma. MT1-MMP subcellular localisation varies with oxygen tension, and, therefore, the aim of the present study was to assess protein i...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798041/ https://www.ncbi.nlm.nih.gov/pubmed/33552276 http://dx.doi.org/10.3892/ol.2020.12419 |
_version_ | 1783634979378429952 |
---|---|
author | Chan, Corey D. Haagensen, Emma J. Tensaout, Hayeit A. Rennie, Katherine J. Gamie, Zakareya Barry, James Birch, Mark A. Gerrand, Craig H. Nisar, Sohail Robson, Craig N. Lunec, John Rankin, Kenneth S. |
author_facet | Chan, Corey D. Haagensen, Emma J. Tensaout, Hayeit A. Rennie, Katherine J. Gamie, Zakareya Barry, James Birch, Mark A. Gerrand, Craig H. Nisar, Sohail Robson, Craig N. Lunec, John Rankin, Kenneth S. |
author_sort | Chan, Corey D. |
collection | PubMed |
description | Increased membrane type-1 matrix metalloproteinase (MT1-MMP) expression in osteosarcoma is predictive of poor prognosis and directs bone metastasis in prostate carcinoma. MT1-MMP subcellular localisation varies with oxygen tension, and, therefore, the aim of the present study was to assess protein interactions between MT1-MMP and the hypoxia inducible factors (HIF-1α and HIF-2α). MT1-MMP protein expression was investigated across a panel of cancer cell lines, including a positive and negative control. The hypoxia-induced alteration in subcellular location of MT1-MMP, HIF-1α and HIF-2α in the U2OS osteosarcoma cell line was assessed using subcellular fractionation. A proximity ligation assay was utilised to assess protein to protein interactions in the osteosarcoma U2OS and prostate carcinoma PC3 cell lines. U2OS and PC3 cells exhibited a significantly increased intra-nuclear interaction between MT1-MMP and HIF-2α in response to hypoxia. The role of this warrants further investigation as it may unveil novel opportunities to target MT1-MMP, which is of particular significance for osteosarcoma since current treatment options are limited. |
format | Online Article Text |
id | pubmed-7798041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-77980412021-02-04 Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells Chan, Corey D. Haagensen, Emma J. Tensaout, Hayeit A. Rennie, Katherine J. Gamie, Zakareya Barry, James Birch, Mark A. Gerrand, Craig H. Nisar, Sohail Robson, Craig N. Lunec, John Rankin, Kenneth S. Oncol Lett Articles Increased membrane type-1 matrix metalloproteinase (MT1-MMP) expression in osteosarcoma is predictive of poor prognosis and directs bone metastasis in prostate carcinoma. MT1-MMP subcellular localisation varies with oxygen tension, and, therefore, the aim of the present study was to assess protein interactions between MT1-MMP and the hypoxia inducible factors (HIF-1α and HIF-2α). MT1-MMP protein expression was investigated across a panel of cancer cell lines, including a positive and negative control. The hypoxia-induced alteration in subcellular location of MT1-MMP, HIF-1α and HIF-2α in the U2OS osteosarcoma cell line was assessed using subcellular fractionation. A proximity ligation assay was utilised to assess protein to protein interactions in the osteosarcoma U2OS and prostate carcinoma PC3 cell lines. U2OS and PC3 cells exhibited a significantly increased intra-nuclear interaction between MT1-MMP and HIF-2α in response to hypoxia. The role of this warrants further investigation as it may unveil novel opportunities to target MT1-MMP, which is of particular significance for osteosarcoma since current treatment options are limited. D.A. Spandidos 2021-02 2020-12-31 /pmc/articles/PMC7798041/ /pubmed/33552276 http://dx.doi.org/10.3892/ol.2020.12419 Text en Copyright: © Chan et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Chan, Corey D. Haagensen, Emma J. Tensaout, Hayeit A. Rennie, Katherine J. Gamie, Zakareya Barry, James Birch, Mark A. Gerrand, Craig H. Nisar, Sohail Robson, Craig N. Lunec, John Rankin, Kenneth S. Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells |
title | Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells |
title_full | Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells |
title_fullStr | Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells |
title_full_unstemmed | Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells |
title_short | Co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells |
title_sort | co-localisation of intra-nuclear membrane type-1 matrix metalloproteinase and hypoxia inducible factor-2α in osteosarcoma and prostate carcinoma cells |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798041/ https://www.ncbi.nlm.nih.gov/pubmed/33552276 http://dx.doi.org/10.3892/ol.2020.12419 |
work_keys_str_mv | AT chancoreyd colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT haagensenemmaj colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT tensaouthayeita colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT renniekatherinej colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT gamiezakareya colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT barryjames colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT birchmarka colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT gerrandcraigh colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT nisarsohail colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT robsoncraign colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT lunecjohn colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells AT rankinkenneths colocalisationofintranuclearmembranetype1matrixmetalloproteinaseandhypoxiainduciblefactor2ainosteosarcomaandprostatecarcinomacells |